U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Here, five nutrition experts review seven foods and drinks to limit or avoid when taking Ozempic and why reducing them may ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

There aren't many biotechs that are more exciting than Viking Therapeutics ( VKTX -7.45%) right now. Thanks to its clinical-stage candidate for weight loss, there's a real chance that this competitor ...